Skip to main content

Advertisement

SpringerLink
Log in

Transurethral Resection of Bladder Tumors: Improving Quality Through New Techniques and Technologies

  • Minimally Invasive Surgery (T Guzzo, Section Editor)
  • Published:
Current Urology Reports Aims and scope Submit manuscript

A Correction to this article was published on 04 April 2019

This article has been updated

Abstract

Purpose of Review

Cystoscopy with transurethral resection of bladder tumors (TURBT) is essential in the diagnosis of bladder cancer as well as the management of non-muscle-invasive disease yet remains a comparatively imprecise procedure secondary to variability among patients, tumors, and surgeons alike. We will review evolving technologies and techniques used to enhance safety and efficacy of TURBT performance and education in the management of bladder cancer.

Recent Findings

Though a generally safe procedure, efficacy of TURBT in terms of complete tumor excision, appropriate pathologic diagnosis, and absence of complications can vary significantly with direct impact on patient outcomes. Application of new techniques including bipolar electrocautery and photodynamic enhancement continues to shape endoscopic management of bladder cancer and improve safety, tumor excision rates, and downstream outcomes.

Summary

High-quality bladder tumor resection is essential for effective bladder cancer management. Technologies such as bipolar electrocautery and photodynamic visualization improve safety and tumor eradication. Improved education and surgical technique will further standardize high-level outcomes for patients undergoing TURBT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

Change history

  • 04 April 2019

    Author Siamak Daneshmand would like to note that this article published in Current Urology Reports inadvertently did not disclose financial information that could possibly be a conflict of interest.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7–30.

    PubMed  Google Scholar 

  2. Beer E. Landmark article May 28, 1910: removal of neoplasms of the urinary bladder. By Edwin Beer. JAMA. 1983;250(10):1324–5.

    Article  CAS  PubMed  Google Scholar 

  3. Cohen RA, Brown RS. Clinical practice. Microscopic hematuria. N Engl J Med. 2003;348(23):2330–8.

    Article  PubMed  Google Scholar 

  4. National Collaborating Centre for Cancer (UK). Bladder Cancer: Diagnosis and Management [Internet]. London: National Institute for Health and Care Excellence (UK); 2015 [cited 2016 Oct 27]. (National Institute for Health and Clinical Excellence: Guidance). Available from: http://www.ncbi.nlm.nih.gov/books/NBK305022/

  5. Professionals S-O. Non-muscle-invasive Bladder Cancer [Internet]. Uroweb. 2015 [cited 2016 Oct 27]. Available from: https://uroweb.org/guideline/non-muscle-invasive-bladder-cancer/

  6. Non-Muscle Invasive Bladder Cancer: American Urological Association [Internet]. [cited 2016]. Available from: http://www.auanet.org/education/guidelines/non-muscle-invasive-bladder-cancer.cfm

  7. Tan WS, Rodney S, Lamb B, Feneley M, Kelly J. Management of non-muscle invasive bladder cancer: a comprehensive analysis of guidelines from the United States, Europe and Asia. Cancer Treat Rev. 2016;47:22–31.

    Article  PubMed  Google Scholar 

  8. Sylvester RJ, van der Meijden APM, Oosterlinck W, Witjes JA, Bouffioux C, Denis L, et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol. 2006;49(3):466. -465-477

    Article  PubMed  Google Scholar 

  9. Svatek RS, Hollenbeck BK, Holmäng S, Lee R, Kim SP, Stenzl A, et al. The economics of bladder cancer: costs and considerations of caring for this disease. Eur Urol. 2014;66(2):253–62.

    Article  PubMed  Google Scholar 

  10. • Matulewicz RS, Sharma V, McGuire BB, Oberlin DT, Perry KT, Nadler RB. The effect of surgical duration of transurethral resection of bladder tumors on postoperative complications: an analysis of ACS NSQIP data. Urol Oncol. 2015;33(8):338.e19–24. Evaluation of impact of surgical duration on complications from TURBT in ACS NSQIP database demonstrating increased complications with greater operative times.

  11. Hollenbeck BK, Miller DC, Taub D, Dunn RL, Khuri SF, Henderson WG, et al. Risk factors for adverse outcomes after transurethral resection of bladder tumors. Cancer. 2006;106(7):1527–35.

    Article  PubMed  Google Scholar 

  12. Rassweiler J, Teber D, Kuntz R, Hofmann R. Complications of transurethral resection of the prostate (TURP)—incidence, management, and prevention. Eur Urol. 2006;50(5):969–79. discussion 980.

    Article  PubMed  Google Scholar 

  13. Hawary A, Mukhtar K, Sinclair A, Pearce I. Transurethral resection of the prostate syndrome: almost gone but not forgotten. J Endourol. 2009;23(12):2013–20.

    Article  PubMed  Google Scholar 

  14. Singhania P, Nandini D, Sarita F, Hemant P, Hemalata I. Transurethral resection of prostate: a comparison of standard monopolar versus bipolar saline resection. Int Braz J Urol Off J Braz Soc Urol. 2010;36(2):183–9.

    Article  Google Scholar 

  15. Tang Y, Li J, Pu C, Bai Y, Yuan H, Wei Q, et al. Bipolar transurethral resection versus monopolar transurethral resection for benign prostatic hypertrophy: a systematic review and meta-analysis. J Endourol. 2014;28(9):1107–14.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Puppo P, Bertolotto F, Introini C, Germinale F, Timossi L, Naselli A. Bipolar transurethral resection in saline (TURis): outcome and complication rates after the first 1000 cases. J Endourol. 2009;23(7):1145–9.

    Article  PubMed  Google Scholar 

  17. Gupta NP, Saini AK, Dogra PN, Seth A, Kumar R. Bipolar energy for transurethral resection of bladder tumours at low-power settings: initial experience. BJU Int. 2011;108(4):553–6.

    Article  PubMed  Google Scholar 

  18. Xishuang S, Deyong Y, Xiangyu C, Tao J, Quanlin L, Hongwei G, et al. Comparing the safety and efficiency of conventional monopolar, plasmakinetic, and holmium laser transurethral resection of primary non-muscle invasive bladder cancer. J Endourol. 2010;24(1):69–73.

    Article  PubMed  Google Scholar 

  19. Mashni J, Godoy G, Haarer C, Dalbagni G, Reuter VE, Al-Ahmadie H, et al. Prospective evaluation of plasma kinetic bipolar resection of bladder cancer: comparison to monopolar resection and pathologic findings. Int Urol Nephrol. 2014;46(9):1699–705.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Del Rosso A, Pace G, Masciovecchio S, Saldutto P, Galatioto GP, Vicentini C. Plasmakinetic bipolar versus monopolar transurethral resection of non-muscle invasive bladder cancer: a single center randomized controlled trial. Int J Urol Off J Jpn Urol Assoc. 2013;20(4):399–403.

    CAS  Google Scholar 

  21. • Venkatramani V, Panda A, Manojkumar R, Kekre NS. Monopolar versus bipolar transurethral resection of bladder tumors: a single center, parallel arm, randomized, controlled trial. J Urol. 2014;191(6):1703–7. Randomized trail evaluating use of monopolar versus bipolar energy for TURBTs. Similar outcomes between the two arms though decreased frequency of severe cautery artifact in the bipolar arm.

  22. Sugihara T, Yasunaga H, Horiguchi H, Matsui H, Nishimatsu H, Nakagawa T, et al. Comparison of perioperative outcomes including severe bladder injury between monopolar and bipolar transurethral resection of bladder tumors: a population based comparison. J Urol. 2014;192(5):1355–9.

    Article  PubMed  Google Scholar 

  23. Zhao C, Tang K, Yang H, Xia D, Chen Z. Bipolar versus monopolar transurethral resection of nonmuscle-invasive bladder cancer: a meta-analysis. J Endourol. 2016;30(1):5–12.

    Article  PubMed  Google Scholar 

  24. Lagerveld BW, Koot RAC, Smits GAHJ. Thermal artifacts in bladder tumors following loop endoresection: electrovaporization v electrocauterization. J Endourol. 2004;18(6):583–6.

    PubMed  Google Scholar 

  25. Wang DS, Bird VG, Leonard VY, Plumb SJ, Konety B, Williams RD, et al. Use of bipolar energy for transurethral resection of bladder tumors: pathologic considerations. J Endourol Endourol Soc. 2004;18(6):578–82.

    Article  Google Scholar 

  26. Babjuk M, Böhle A, Burger M, Capoun O, Cohen D, Compérat EM, et al. EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. Eur Urol. 2016.

  27. Gendy R, Delprado W, Brenner P, Brooks A, Coombes G, Cozzi P, et al. Repeat transurethral resection for non-muscle-invasive bladder cancer: a contemporary series. BJU Int. 2016;117(Suppl 4):54–9.

    Article  PubMed  Google Scholar 

  28. Brausi M, Collette L, Kurth K, van der Meijden AP, Oosterlinck W, Witjes JA, et al. Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies. Eur Urol. 2002;41(5):523–31.

    Article  PubMed  Google Scholar 

  29. Herr HW. Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy. J Urol. 2005;174(6):2134–7.

    Article  PubMed  Google Scholar 

  30. Schwaibold HE, Sivalingam S, May F, Hartung R. The value of a second transurethral resection for T1 bladder cancer. BJU Int. 2006;97(6):1199–201.

    Article  PubMed  Google Scholar 

  31. Dwivedi US, Kumar A, Das SK, Trivedi S, Kumar M, Sunder S, et al. Relook TURBT in superficial bladder cancer: its importance and its correlation with the tumor ploidy. Urol Oncol. 2009;27(5):514–9.

    Article  PubMed  Google Scholar 

  32. Herr HW. Role of repeat resection in non-muscle-invasive bladder cancer. J Natl Compr Cancer Netw JNCCN. 2015;13(8):1041–6.

    Article  Google Scholar 

  33. Divrik RT, Sahin AF, Yildirim U, Altok M, Zorlu F. Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival: a prospective randomised clinical trial. Eur Urol. 2010;58(2):185–90.

    Article  PubMed  Google Scholar 

  34. Adiyat KT, Katkoori D, Soloway CT, De los Santos R, Manoharan M, Soloway MS. “complete transurethral resection of bladder tumor”: are the guidelines being followed? Urology. 2010;75(2):365–7.

    Article  PubMed  Google Scholar 

  35. Daneshmand S, Schuckman AK, Bochner BH, Cookson MS, Downs TM, Gomella LG, et al. Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USA. Nat Rev Urol. 2014;11(10):589–96.

    Article  CAS  PubMed  Google Scholar 

  36. Kołodziej A, Krajewski W, Matuszewski M, Tupikowski K. Review of current optical diagnostic techniques for non-muscle-invasive bladder cancer. Cent Eur J Urol. 2016;69(2):150–6.

    Google Scholar 

  37. Fradet Y, Grossman HB, Gomella L, Lerner S, Cookson M, Albala D, et al. A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study. J Urol. 2007;178(1):68–73. discussion 73.

    Article  PubMed  Google Scholar 

  38. Stenzl A, Burger M, Fradet Y, Mynderse LA, Soloway MS, Witjes JA, et al. Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancer. J Urol. 2010;184(5):1907–13.

    Article  PubMed  PubMed Central  Google Scholar 

  39. •• Grossman HB, Stenzl A, Fradet Y, Mynderse LA, Kriegmair M, Witjes JA, et al. Long-term decrease in bladder cancer recurrence with hexaminolevulinate enabled fluorescence cystoscopy. J Urol. 2012;188(1):58–62. Long-term outcomes of randomized study demonstrating impact of improved tumor resection enhanced by photodynamic diagnosis.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Rink M, Babjuk M, Catto JWF, Jichlinski P, Shariat SF, Stenzl A, et al. Hexyl aminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: a critical review of the current literature. Eur Urol. 2013;64(4):624–38.

    Article  PubMed  Google Scholar 

  41. • Burger M, Grossman HB, Droller M, Schmidbauer J, Hermann G, Drăgoescu O, et al. Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data. Eur Urol. 2013;64(5):846–54. Meta-analysis of studies evaluating outcomes with addition of blue light cystoscopy in completion of TURBT.

    Article  PubMed  Google Scholar 

  42. Witjes JA, Babjuk M, Gontero P, Jacqmin D, Karl A, Kruck S, et al. Clinical and cost effectiveness of hexaminolevulinate-guided blue-light cystoscopy: evidence review and updated expert recommendations. Eur Urol. 2014;66(5):863–71.

    Article  PubMed  Google Scholar 

  43. Naselli A, Introini C, Bertolotto F, Spina B, Puppo P. Feasibility of transurethral resection of bladder lesion performed entirely by means of narrow-band imaging. J Endourol. 2010;24(7):1131–4.

    Article  PubMed  Google Scholar 

  44. Naito S, Algaba F, Babjuk M, Bryan RT, Sun Y-H, Valiquette L, et al. The clinical research Office of the Endourological Society (CROES) multicentre randomised trial of narrow band imaging-assisted transurethral resection of bladder tumour (TURBT) versus conventional white light imaging-assisted TURBT in primary non-muscle-invasive bladder cancer patients: trial protocol and 1-year results. Eur Urol. 2016;70(3):506–15.

    Article  PubMed  Google Scholar 

  45. Kausch I, Sommerauer M, Montorsi F, Stenzl A, Jacqmin D, Jichlinski P, et al. Photodynamic diagnosis in non-muscle-invasive bladder cancer: a systematic review and cumulative analysis of prospective studies. Eur Urol. 2010;57(4):595–606.

    Article  PubMed  Google Scholar 

  46. • Bos D, Allard CB, Dason S, Ruzhynsky V, Kapoor A, Shayegan B. Impact of resident involvement in endoscopic bladder cancer surgery on pathological outcomes. Scand J Urol. 2016;50(3):234–8. Recent retrospective review demonstrating variability in clinical outcomes from TURBT. Indicates surgeon experience relevant among other clinical factors.

    Article  PubMed  Google Scholar 

  47. Huang J, Fu J, Zhan H, Xie K, Liu B, Yang F, et al. Analysis of the absence of the detrusor muscle in initial transurethral resected specimens and the presence of residual tumor tissue. Urol Int. 2012;89(3):319–25.

    Article  PubMed  Google Scholar 

  48. Mariappan P, Zachou A, Grigor KM, Edinburgh Uro-Oncology Group. Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience. Eur Urol. 2010;57(5):843–9.

    Article  PubMed  Google Scholar 

  49. Shoshany O, Mano R, Margel D, Baniel J, Yossepowitch O. Presence of detrusor muscle in bladder tumor specimens—predictors and effect on outcome as a measure of resection quality. Urol Oncol. 2014;32(1):40.e17–22.

    Article  Google Scholar 

  50. Kruck S, Bedke J, Hennenlotter J, Amend B, Merseburger A, Stenzl A, et al. Virtual bladder tumor transurethral resection: an objective evaluation tool to overcome learning curves with and without photodynamic diagnostics. Urol Int. 2011;87(2):138–42.

    Article  PubMed  Google Scholar 

  51. Aydin A, Shafi AMA, Shamim Khan M, Dasgupta P, Ahmed K. Current status of simulation and training models in urological surgery: a systematic review. J Urol. 2016;196(2):312–20.

    Article  PubMed  Google Scholar 

  52. de Vries AH, van Genugten HGJ, Hendrikx AJM, Koldewijn EL, Schout BMA, Tjiam IM, et al. The Simbla TURBT simulator in urological residency training: from needs analysis to validation. J Endourol. 2015;30(5):580–7.

    Article  Google Scholar 

  53. • Bazargani S, Djaladat H, Schuckman AK, Hugen C, Daneshmand S. Blue light cystoscopy with Cysview: The USC experience. Video publication demonstrating both application of blue light cystoscopy and as “intermittent resection technique.”

  54. Liem EI, de Reijke TM. Can we improve transurethral resection of the bladder tumour for nonmuscle invasive bladder cancer? Curr Opin Urol. 2016.

  55. Wu Y-P, Lin T-T, Chen S-H, Xu N, Wei Y, Huang J-B, et al. Comparison of the efficacy and feasibility of en bloc transurethral resection of bladder tumor versus conventional transurethral resection of bladder tumor: a meta-analysis. Medicine (Baltimore). 2016;95(45):e5372.

    Article  Google Scholar 

  56. Kramer MW, Rassweiler JJ, Klein J, Martov A, Baykov N, Lusuardi L, et al. En bloc resection of urothelium carcinoma of the bladder (EBRUC): a European multicenter study to compare safety, efficacy, and outcome of laser and electrical en bloc transurethral resection of bladder tumor. World J Urol. 2015;33(12):1937–43.

    Article  PubMed  Google Scholar 

  57. Hurle R, Lazzeri M, Colombo P, Buffi N, Morenghi E, Peschechera R, et al. “en bloc” resection of nonmuscle invasive bladder cancer: a prospective single-center study. Urology. 2016;90:126–30.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. USC Norris Comprehensive Cancer Center, 1441 Eastlake Avenue, Suite 7416, Los Angeles, CA, 90089, USA

    Daniel Zainfeld & Siamak Daneshmand

Authors
  1. Daniel Zainfeld
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Siamak Daneshmand
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Siamak Daneshmand.

Ethics declarations

Conflict of Interest

Daniel Zainfeld and Siamak Daneshmand declare no potential conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Minimally Invasive Surgery

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zainfeld, D., Daneshmand, S. Transurethral Resection of Bladder Tumors: Improving Quality Through New Techniques and Technologies. Curr Urol Rep 18, 34 (2017). https://doi.org/10.1007/s11934-017-0680-0

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11934-017-0680-0

Keywords

Search

Navigation